PLUS Diagnostics is a US anatomic pathology company which offers a full range of multi-specialty services, and under the agreement it will build awareness of ConfirmMDx for Prostate Cancer, through its national network of urologists.
ConfirmMDx for Prostate Cancer is a laboratory-developed test (LDT), which was performed at MDxHealth's Irvine, California laboratory, which is intended to assist urologists with identifying men who may safely refrain from unnecessary repeat biopsies.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia